GS-5885
Showing 1 - 25 of 311
Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],
Completed
- Hepatitis B
- Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
- +2 more
-
Baltimore, MarylandInstitute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021
Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir
Completed
- Chronic Hepatitis C Infection
- +2 more
- Ledipasvir/Sofosbuvir
- +4 more
-
Hong Kong, Hong Kong, ChinaHumanity and Health GI and Liver Centre
Aug 27, 2021
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Hepatitis C Virus Infection Trial in Cairo (LDV/SOF)
Completed
- Hepatitis C Virus Infection
-
Cairo, EgyptNational Cancer Institute, Cairo University
Feb 18, 2020
Harvoni in Chronic Hepatitis C Virus (HCV) Infection in Korea
Completed
- Hepatitis C Virus
-
Seongnam-si, Gyeonggido, Korea, Republic of
- +71 more
Nov 24, 2021
Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF, RBV)
Completed
- Hepatitis C Virus Infection
-
Birmingham, Alabama
- +30 more
Feb 18, 2020
Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF)
Completed
- Hepatitis C Virus Infection
-
Boston, Massachusetts
- +20 more
Feb 18, 2020
Chronic HCV Infection Trial in San Antonio (LDV/SOF, RBV, GS-9669)
Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, RBV, SOF/VEL)
Hepatitis C Virus Infection Trial in San Antonio (LDV/SOF, VDV, RBV)
Hepatitis C Virus Infection Trial in Lutherville (LDV/SOF)
Completed
- Hepatitis C Virus Infection
-
Lutherville, Maryland(unnamed)
Oct 19, 2018
Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, SOF, RBV)
Chronic Hepatitis C Virus Trial in San Antonio (LDV/SOF, RBV)
Completed
- Chronic Hepatitis C Virus
-
San Antonio, Texas(unnamed)
Oct 19, 2018
Hepatitis C Virus Infection Trial in Boston (LDV/SOF, Placebo)
Chronic Genotype 4 HCV, Chronic Genotype 5 HCV Trial in France (LDV/SOF)
Completed
- Chronic Genotype 4 HCV
- Chronic Genotype 5 HCV
-
Clermont Ferrand, France
- +4 more
Oct 19, 2018
Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- GS-0272
- Placebo
- (no location specified)
Sep 4, 2023
Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))
Enrolling by invitation
- Alcohol Consumption
- Control
- +2 more
-
Palo Alto, CaliforniaStanford University
May 8, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023
Hepatitis C Virus Infection Trial in United States (LDV/SOF)
Completed
- Hepatitis C Virus Infection
-
San Francisco, California
- +5 more
Oct 19, 2018
Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))
Not yet recruiting
- Genetic Predisposition
- Next-Generation Sequencing (NGS)
-
Tübingen, GermanyUniversity Hospital Tübingen
Sep 22, 2023